Related Experiment Video

Updated: Aug 2, 2026

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Immune response to pneumococcal conjugate and polysaccharide vaccines in otitis-prone and otitis-free children

E D Barnett1, S I Pelton, H J Cabral

  • 1Maxwell Finland Laboratory for Infectious Diseases, Boston Medical Center, and Boston University School of Public Health, Massachusetts 02118, USA. ebarnett@bu.edu

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|August 5, 1999
PubMed

Insights

Pneumococcal conjugate vaccines elicit stronger antibody responses than polysaccharide vaccines in children, particularly those prone to otitis media. This suggests conjugate vaccines may reduce vaccine-type disease in children with recurrent ear infections.

Area of Science:

  • Immunology
  • Pediatrics
  • Vaccinology

Background:

  • Recurrent otitis media is a common childhood illness.
  • Pneumococcal bacteria are a leading cause of otitis media.
  • Vaccination strategies aim to prevent pneumococcal infections.

Purpose of the Study:

  • To compare antibody responses to pneumococcal conjugate vaccine (PCV) versus polysaccharide vaccine (PPSV).
  • To assess vaccine efficacy in otitis-free versus otitis-prone children.
  • To evaluate the potential of PCV in preventing pneumococcal disease in susceptible children.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) was used to measure antibody concentrations.
  • Antibody levels to specific pneumococcal serotypes (6B, 14, 19F, 23F) were quantified.
  • Immune responses were compared between children receiving PCV and PPSV.

Main Results:

  • Children receiving PCV showed significantly higher post-immunization antibody concentrations to all four serotypes compared to PPSV recipients.
  • The enhanced response to PCV was most pronounced in otitis-prone children.
  • Otitis-prone children receiving PCV had higher antibody levels than otitis-free children receiving PCV.

Conclusions:

  • Pneumococcal conjugate vaccine demonstrates superior immunogenicity over polysaccharide vaccine in children.
  • PCV is particularly effective in otitis-prone children, suggesting potential for disease reduction.
  • Pneumococcal conjugate vaccines hold promise for reducing vaccine-serotype diseases, including in children with recurrent otitis media.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens08:47

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens

Published on: April 5, 2019

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...